Skip to content

Effect of millet based instant filler mix on parameters of metabolic syndrome patients - A Randomised Controlled Trial

Utilization of novel technological interventions for development and evaluation of millet based instant filler mix for the management of metabolic syndrome parameters - Nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/111420
Enrollment
78
Registered
2026-05-29
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E888- Other specified metabolic disorders

Interventions

Intervention1: Millet Based Instant Filler Mix: Millet based instant filler mix will be given to metabolic syndrome patients of intervention arm for a period of 04 months as part of their diet (90-100

Sponsors

Nitin Kaushal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Abdominal Obesity 2. Plus at least two of the following a. Reduced High density lipoprotein (HDL) cholesterol b. Impaired fasting blood glucose c. High blood pressure d. Elevated Triglycerides or treatment for elevated triglycerides

Exclusion criteria

Exclusion criteria: 1. Age less than 18 years 2. Pregnant women 3.Patients with comorbidities other than the ones included in study. 4.Conditions interfering with body weight measurement such as ascites or oedema.

Design outcomes

Primary

MeasureTime frame
1.To develop millet based instant filler mix using novel technology 2.To evaluate the instant filler mix for nutritional and food safety quality parameters. a)Nutritional Parameters i.Crude Fibre ii.Protein iii.Carbohydrates iv.Total Ash v.Energy vi.Fat b)Food safety parameters i.E Coli should be absent ii.V Cholerae - should be absent iii.Samonella sp - should be absent/ 25 gm iv.Total Plate Count 50,000/gm v.S Aureus - should be absent/ 25 gm vi.B Cereus - should be absent vii.Clostridium - should be absent Timepoint: Objective 1 - 06 months Objective 2 - 03 months Objective 3 - 03 months Objective 4 - 03 Months

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactNitin Kaushal

PGIMER, Chandigarh

poonamkhanna05@gmail.com9872534628

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026